Blog
RSS FeedPosted by Michael Wonder on 14 Sep 2018
EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?
14 September 2018 - The EU’s centralized procedure for the authorization of a new drug is performed by the EMA. ...
Posted by Michael Wonder on 23 Jan 2017
Conditional marketing authorisations give patients access to important new medicines earlier
23 January 2017 - EMA publishes report with data collected between 2006 and June 2016. ...